Search

everythinglearnresearchcommunity

for

Search:↓

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Genetic testing can identify causes of rare hair loss disorders in children, but no treatments exist.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

Dark skin has stronger barriers and structure due to specific gene activity.

Topical and oral minoxidil are the best treatments for monilethrix.

Cell detachment, not autoantibody binding, causes major changes in pemphigus.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

PGD2 stops hair growth and is higher in bald men with AGA.

Dried blood spots can be as stable as frozen liquid samples for storing certain metabolites.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Blocking a protein called prostaglandin D2 might help treat hair loss.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Ganser syndrome may result from both organic and psychogenic factors.

A new EDA gene mutation was found in a Chinese family with a specific skin disorder.

Pregnancies in a woman with the Donohue mutation were managed with genetic testing, resulting in three healthy infants.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

A new mouse mutation causes skin and hair defects due to a gene change.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

The patient with lupus and Degos' disease showed significant improvement with treatment.

TSPO might help treat anxiety and depression.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.